Evidence map›Paper›PMID 29389861›Full record

ReviewInternational journal of molecular sciences2018

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.

Carmine Carbone, Geny Piro, Valeria Merz, Francesca Simionato, Raffaela Santoro, Camilla Zecchetto, Giampaolo Tortora, Davide Melisi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 221 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Carmine CarboneDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 37134 Verona, Italy. carmine.carbone@univr.it.ORCID 0000-0001-5168-747X
Geny PiroDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 37134 Verona, Italy. genypiro@hotmail.com.
Valeria MerzMedical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. valeriamerz@gmail.com.ORCID 0000-0002-2120-1923
Francesca SimionatoDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 37134 Verona, Italy. franziskasimio.fs@gmail.com.
Raffaela SantoroDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 37134 Verona, Italy. raffaela.santoro@univr.it.
Camilla ZecchettoMedical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. camilla.zecchetto@gmail.com.
Giampaolo TortoraLaboratory of Oncology and Molecular Therapy, Department of Medicine, University of Verona, 37134 Verona, Italy. giampaolo.tortora@univr.it.
Davide MelisiDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 37134 Verona, Italy. davide.melisi@univr.it.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Altered expression of secreted factors by tumor cells or cells of the tumor microenvironment is a key event in cancer development and progression. In the last decade, emerging evidences supported the autocrine and paracrine activity of the members of the Angiopoietin-like (ANGPTL) protein family in angiogenesis, inflammation and in the regulation of different steps of carcinogenesis and metastasis development. Thus, ANGPTL proteins become attractive either as prognostic or predictive biomarkers, or as novel target for cancer treatment. Here, we outline the current knowledge about the functions of the ANGPTL proteins in angiogenesis, cancer progression and metastasis. Moreover, we discuss the most recent evidences sustaining their role as prognostic or predictive biomarkers for cancer therapy. Although the role of ANGPTL proteins in cancer has not been fully elucidated, increasing evidence suggest their key effects in the proliferative and invasive properties of cancer cells. Moreover, given the common overexpression of ANGPTL proteins in several aggressive solid tumors, and their role in tumor cells and cells of the tumor microenvironment, the field of research about ANGPTL proteins network may highlight new potential targets for the development of future therapeutic strategies.

Indexed as

Multigene FamilyAngiopoietin-like ProteinsCarcinogenesisGene Expression Regulation, NeoplasticHumansInflammationNeoplasmsNeovascularization, PathologicPrognosisAngiopoietin-like Proteinsangiogenesisangiopoietin-like proteinscancerinflammation

Identifiers

PMID29389861
PMCPMC5855653
OpenAlexW2792834220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.